A carregar...
Reports of Lactic Acidosis Attributed to Metformin, 2015–2018
OBJECTIVE: In 2016, the U.S. Food and Drug Administration (FDA) revised metformin’s label to permit use in patients with mild-moderate chronic kidney disease. We sought to determine whether this change was associated with increased reports of metformin-associated lactic acidosis (MALA) to the FDA’s...
Na minha lista:
| Publicado no: | Diabetes Care |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Diabetes Association
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7011199/ https://ncbi.nlm.nih.gov/pubmed/31597667 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-0923 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|